Download PDF
Exp Clin Endocrinol Diabetes 2021; 129(03): 241-249
DOI: 10.1055/a-1217-7208
Review

Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions

Tina Kienitz
1   Endocrinology in Charlottenburg, Berlin, Germany
,
Stefanie Hahner
2   Endocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany
,
Stephanie Burger-Stritt
2   Endocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany
,
Marcus Quinkler
1   Endocrinology in Charlottenburg, Berlin, Germany
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Adrenal insufficiency (AI) requires life-long treatment with glucocorticoid replacement therapy. Over- or under-substitution carries the risk of increased morbidity in the form of side effects or adrenal crises. Glucocorticoid replacement therapy needs to be flexible with dose adaptation in special situations. This could not be managed by medical personnel on a daily basis, but requires an educated patient who has a good knowledge of the disease, understands his medical therapy and is able to perform situational dose adaptation. The rarity of the disease in combination with the need to respond to stressful situations with rapid glucocorticoid dose adjustment underlines that a well-trained patient is crucial for optimal management of the disease.

In this literature review we provide background information further clarifying the need of education in patients with AI including the current shortcomings of medical therapy and of the treatment of patients with AI. We outline the aims of therapeutic patient education, present the concept of structured patient education in Germany, and discuss available results of patient group education programs. Furthermore, we propose strategies how therapeutic patient education for adrenal insufficiency can be organized under COVID-19 pandemic conditions.

Key words

adrenal crisis - hydrocortisone - secondary adrenal insufficiency - emergency card


Publication History

Received: 27 March 2020
Received: 25 June 2020

Accepted: 08 July 2020

Article published online:
06 August 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Erichsen MM, Lovas K, Skinningsrud B. et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 2009; 94: 4882-90 Epub 2009/10/28.
    CrossrefPubMedSearch in Google Scholar
  • 2 Burman P, Mattsson AF, Johannsson G. et al. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab 2013; 98: 1466-75 Epub 2013/03/05
    CrossrefPubMedSearch in Google Scholar
  • 3 Sherlock M, Ayuk J, Tomlinson JW. et al. Mortality in patients with pituitary disease. Endocr Rev. 2010; 31: 301-42 Epub 2010/01/21
    CrossrefPubMedSearch in Google Scholar
  • 4 Bensing S, Brandt L, Tabaroj F. et al. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) 2008; 69: 697-704 Epub 2008/08/30
    CrossrefPubMedSearch in Google Scholar
  • 5 Falhammar H, Frisen L, Norrby C. et al. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2014; 99: E2715-21 Epub 2014/10/04
    CrossrefPubMedSearch in Google Scholar
  • 6 Bergthorsdottir R, Leonsson-Zachrisson M, Oden A. et al. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006; 91: 4849-53 Epub 2006/09/14.
    CrossrefPubMedSearch in Google Scholar
  • 7 Smans LC, Souverein PC, Leufkens HG. et al. Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study. Eur J Endocrinol 2013; 168: 609-14. Epub 2013/02/07
    CrossrefPubMedSearch in Google Scholar
  • 8 Mebrahtu TF, Morgan AW, Keeley A. et al. Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England. J Clin Endocrinol Metab 2019; Epub 2019/04/23
    CrossrefPubMedSearch in Google Scholar
  • 9 Sherlock M, Reulen RC, Alonso AA. et al. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 2009; 94: 4216-23 Epub 2009/10/08
    CrossrefPubMedSearch in Google Scholar
  • 10 Zueger T, Kirchner P, Herren C. et al. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab 2012; 97: E1938-42 Epub 2012/08/09
    CrossrefPubMedSearch in Google Scholar
  • 11 Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990; 336: 285-8 Epub 1990/08/04.
    CrossrefPubMedSearch in Google Scholar
  • 12 Clayton RN, Jones PW, Reulen RC. et al. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol. 2016; 4(7):569-76. Epub 2016/06/0 7
    CrossrefPubMedSearch in Google Scholar
  • 13 Quinkler M, Ekman B, Zhang P. et al. Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations. Clin Endocrinol (Oxf) 2018; 89: 30-5 Epub 2018/04/24.
    CrossrefPubMedSearch in Google Scholar
  • 14 Behan LA, Carmody D, Rogers B. et al. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients. Eur J Endocrinol 2016; 174: 791-9 Epub 2016/03/31
    CrossrefPubMedSearch in Google Scholar
  • 15 Werumeus Buning J, van Faassen M, Brummelman P. et al. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial. J Clin Endocrinol Metab 2016; 101: 3691-9 Epub 2016/08/05.
    CrossrefPubMedSearch in Google Scholar
  • 16 Allolio B, Lang K, Hahner S. Addisonian crisis in a young man with atypical anorexia nervosa. Nat Rev Endocrinol 2011; 7: 115-21. Epub 2010/12/24
    CrossrefPubMedSearch in Google Scholar
  • 17 White K, Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event. Eur J Endocrinol 2010; 162: 115-20. Epub 2009/09/25
    CrossrefPubMedSearch in Google Scholar
  • 18 Hahner S, Loeffler M, Bleicken B. et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 2010; 162: 597-602 Epub 2009/12/04.
    CrossrefPubMedSearch in Google Scholar
  • 19 Omori K, Nomura K, Shimizu S. et al. Risk factors for adrenal crisis in patients with adrenal insufficiency. Endocr J. 2003; 50: 745-52 Epub 2004/01/08
    CrossrefPubMedSearch in Google Scholar
  • 20 Reisch N, Willige M, Kohn D. et al. Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur J Endocrinol 2012; 167: 35-42 Epub 2012/04/20
    CrossrefPubMedSearch in Google Scholar
  • 21 Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol 2015; 172: R115-24. Epub 2014/10/08
    CrossrefPubMedSearch in Google Scholar
  • 22 Hahner S, Spinnler C, Fassnacht M. et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 2015; 100: 407-16. Epub 2014/11/25
    CrossrefPubMedSearch in Google Scholar
  • 23 Husebye ES, Allolio B, Arlt W. et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-15 Epub 2013/12/18.
    CrossrefPubMedSearch in Google Scholar
  • 24 Grossman A, Johannsson G, Quinkler M. et al. Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol 2013; 169: R165-75 Epub 2013/09/14
    CrossrefPubMedSearch in Google Scholar
  • 25 Murray RD, Ekman B, Uddin S. et al. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR. Clin Endocrinol (Oxf) 2017; 86: 340-6 Epub 2016/11/02
    CrossrefPubMedSearch in Google Scholar
  • 26 Bornstein SR, Allolio B, Arlt W. et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 364-89 Epub 2016/01/14.
    CrossrefPubMedSearch in Google Scholar
  • 27 Esteban NV, Loughlin T, Yergey AL. et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72: 39-45 Epub 1991/01/01
    CrossrefPubMedSearch in Google Scholar
  • 28 Mah PM, Jenkins RC, Rostami-Hodjegan A. et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004; 61: 367-75 Epub 2004/09/10.
    CrossrefPubMedSearch in Google Scholar
  • 29 Weise M, Drinkard B, Mehlinger SL. et al. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab 2004; 89: 3679-84 Epub 2004/08/05.
    CrossrefPubMedSearch in Google Scholar
  • 30 Simunkova K, Jovanovic N, Rostrup E. et al. Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. Eur J Endocrinol 2016; 174: 97-105. Epub 2015/10/24
    CrossrefPubMedSearch in Google Scholar
  • 31 Quinkler M, Hahner S. What is the best long-term management strategy for patients with primary adrenal insufficiency?. Clin Endocrinol (Oxf) 2012; 76: 21-5 Epub 2011/05/19
    CrossrefPubMedSearch in Google Scholar
  • 32 Quinkler M, Beuschlein F, Hahner S. et al. Adrenal cortical insufficiency--a life threatening illness with multiple etiologies. Dtsch Arztebl Int 2013; 110(51-52): 882-8 Epub 2014/02/18.
    CrossrefPubMedSearch in Google Scholar
  • 33 Quinkler M, Hahner S, Johannsson G. et al. Saving lives of patients with adrenal insufficiency: a pan-European initiative?. Clin Endocrinol (Oxf) 2014; 80: 319-21. Epub 2013/12/05.
    CrossrefPubMedSearch in Google Scholar
  • 34 Quinkler M, Dahlqvist P, Husebye ES. et al. A European Emergency Card for adrenal insufficiency can save lives. Eur J Intern Med 2015; 26: 75-6 Epub 2014/12/17.
    CrossrefPubMedSearch in Google Scholar
  • 35 Petersenn S, Honegger J, Quinkler M. National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency. Horm Metab Res 2017; 49: 580-8 Epub 2017/03/30
    Thieme ConnectPubMedSearch in Google Scholar
  • 36 Hahner S, Hemmelmann N, Quinkler M. et al. Timelines in the management of adrenal crisis - targets, limits and reality. Clin Endocrinol (Oxf) 2015; 82: 497-502 Epub 2014/09/10
    CrossrefPubMedSearch in Google Scholar
  • 37 Burger-Stritt S, Kardonski P, Pulzer A. et al. Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study. Clin Endocrinol (Oxf) 2018; 89: 22-9 Epub 2018/04/05
    CrossrefPubMedSearch in Google Scholar
  • 38 Kampmeyer D, Lehnert H, Moenig H. et al. Experience pays off! Endocrine centres are essential in the care of patients with adrenal insufficiency. Eur J Intern Med 2016; 35: e27-e28 Epub 2016/07/23
    CrossrefPubMedSearch in Google Scholar
  • 39 Harbeck B, Brede S, Witt C. et al. Glucocorticoid replacement therapy in adrenal insufficiency--a challenge to physicians?. Endocr J. 2015; 62: 463-8 Epub 2015/03/06.
    CrossrefPubMedSearch in Google Scholar
  • 40 White KG. A retrospective analysis of adrenal crisis in steroid-dependent patients: causes, frequency and outcomes. BMC Endocr Disord 2019; 19: 129 Epub 2019/12/04
    CrossrefPubMedSearch in Google Scholar
  • 41 Forss M, Batcheller G, Skrtic S. et al. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord 2012; 12: 8. Epub 2012/06/15
    CrossrefPubMedSearch in Google Scholar
  • 42 Tiemensma J, Andela CD, Pereira AM. et al. Patients with adrenal insufficiency hate their medication: concerns and stronger beliefs about the necessity of hydrocortisone intake are associated with more negative illness perceptions. J Clin Endocrinol Metab 2014; 99: 3668-76 Epub 2014/09/17
    CrossrefPubMedSearch in Google Scholar
  • 43 Chapman SC, Llahana S, Carroll P. et al. Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information. Clin Endocrinol (Oxf) 2016; 84: 664-71 Epub 2015/12/08
    CrossrefPubMedSearch in Google Scholar
  • 44 Schofl C, Mayr B, Maison N. et al. Daily adjustment of glucocorticoids by patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2019; 91: 256-62 Epub 2019/05/06
    CrossrefPubMedSearch in Google Scholar
  • 45 Guignat L. Therapeutic patient education in adrenal insufficiency. Ann Endocrinol (Paris) 2018; 79: 167-73 Epub 2018/04/03.
    CrossrefPubMedSearch in Google Scholar
  • 46 Burger-Stritt S, Hahner S. [Adrenal Insufficiency]. Dtsch Med Wochenschr 2016; 141: 1740-2. Epub 2016/12/03.
    Thieme ConnectPubMedSearch in Google Scholar
  • 47 Repping-Wuts HJ, Stikkelbroeck NM, Noordzij A. et al. A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol 2013; 169: 17-22 Epub 2013/05/03.
    CrossrefPubMedSearch in Google Scholar
  • 48 Eff A, Burger-Stritt S, Quinkler M. Evaluation of a German-wide Education Programme For Patients With Adrenal Insufficiency – First Interim Analysis. Poster, DACH-Tagung München 2016; P01-P13
    PubMedSearch in Google Scholar
  • 49 Fleming L, Knafl K, Knafl G. et al. Parental management of adrenal crisis in children with congenital adrenal hyperplasia. J Spec Pediatr Nurs 2017; 22: 4. Epub 2017/08/05
    CrossrefPubMedSearch in Google Scholar
  • 50 Meyer G, Koch M, Herrmann E. et al. Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison's disease. Endocrine 2018; 60: 355-61. Epub 2018/02/02.
    CrossrefPubMedSearch in Google Scholar
  • 51 Arlt W, Baldeweg SE, Pearce SHS. et al. Endocrinology in the time of COVID-19: Management of adrenal insufficiency. Eur J Endocrinol 2020; Epub 2020/05/08.
    CrossrefPubMedSearch in Google Scholar
  • 52 Kaiser UB, Mirmira RG, Stewart PM. Our Response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab 2020; 105: 5. Epub 2020/04/02
    CrossrefPubMedSearch in Google Scholar
  • 53 Isidori AM, Pofi R, Hasenmajer V. et al. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol 2020; Epub 2020/04/27.
    CrossrefPubMedSearch in Google Scholar
  • 54 Block P, Hoffman M, Raabe IJ. et al. Social Network-Based Distancing Strategies to Flatten the COVID-19 Curve in a Post-Lockdown World. Nat Hum Behav 2020; 4: 588-596 Epub 2020 Jun 4
    CrossrefPubMedSearch in Google Scholar